Integrated Platform for Production and Purification of Human Pluripotent Stem Cell-Derived Neural Precursors

[1]  Clay W Scott,et al.  Human induced pluripotent stem cells and their use in drug discovery for toxicity testing. , 2013, Toxicology letters.

[2]  C. Laver,et al.  Differentiation of human embryonic stem cells using size-controlled embryoid bodies and negative cell selection in the production of photoreceptor precursor cells. , 2013, Tissue engineering. Part C, Methods.

[3]  Louise C. Laurent,et al.  Deriving dopaminergic neurons for clinical use. A practical approach , 2013, Scientific Reports.

[4]  A. Bosio,et al.  Efficient neuronal in vitro and in vivo differentiation after immunomagnetic purification of mESC derived neuronal precursors. , 2013, Stem cell research.

[5]  D. Cyranoski.  Stem cells cruise to clinic , 2013, Nature.

[6]  O. Yanuka,et al.  Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen. , 2013, Cell stem cell.

[7]  J. Takahashi,et al.  Therapeutic application of stem cell technology toward the treatment of Parkinson's disease. , 2013, Biological & pharmaceutical bulletin.

[8]  Bahram Valamehr,et al.  Optimized Surface Markers for the Prospective Isolation of High-Quality hiPSCs using Flow Cytometry Selection , 2013, Scientific Reports.

[9]  J. C. Belmonte,et al.  Characterization of pluripotent stem cells , 2013, Nature Protocols.

[10]  Maria Margarida Diogo,et al.  Separation technologies for stem cell bioprocessing , 2012, Biotechnology and bioengineering.

[11]  F. J. Livesey,et al.  Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks , 2012, Nature Protocols.

[12]  W. Cui,et al.  Identification and Characterisation of the Early Differentiating Cells in Neural Differentiation of Human Embryonic Stem Cells , 2012, PloS one.

[13]  Ofer Binah,et al.  Cardiomyocytes derived from human pluripotent stem cells for drug screening. , 2012, Pharmacology & therapeutics.

[14]  Matthew Trotter,et al.  Capture of Neuroepithelial-Like Stem Cells from Pluripotent Stem Cells Provides a Versatile System for In Vitro Production of Human Neurons , 2012, PloS one.

[15]  Alois Jungbauer,et al.  Selective removal of undifferentiated human embryonic stem cells using magnetic activated cell sorting followed by a cytotoxic antibody. , 2012, Tissue engineering. Part A.

[16]  D. Surmeier,et al.  Floor plate-derived dopamine neurons from hESCs efficiently engraft in animal models of PD , 2011, Nature.

[17]  Ji Young Kim,et al.  Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery , 2011, Experimental & Molecular Medicine.

[18]  Donghui Jing,et al.  Stem Cell Bioprocessing for Regenerative Medicine , 2011 .

[19]  D. Sahoo,et al.  An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells , 2011, Nature Biotechnology.

[20]  T. Akaike,et al.  Culture of human pluripotent stem cells using completely defined conditions on a recombinant E-cadherin substratum , 2010, BMC Developmental Biology.

[21]  E. Endl,et al.  Laser-Assisted Photoablation of Human Pluripotent Stem Cells from Differentiating Cultures , 2010, Stem Cell Reviews and Reports.

[22]  Alois Jungbauer,et al.  Stem cell separation: A bottleneck in stem cell therapy , 2010, Biotechnology journal.

[23]  O. Lindvall,et al.  Emerging concepts in neural stem cell research: autologous repair and cell-based disease modelling , 2009, The Lancet Neurology.

[24]  Shinya Yamanaka,et al.  A Fresh Look at iPS Cells , 2009, Cell.

[25]  O. Brüstle,et al.  A rosette-type, self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration , 2009, Proceedings of the National Academy of Sciences.

[26]  M. Tomishima,et al.  Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling , 2009, Nature Biotechnology.

[27]  C. Fong,et al.  Separation of SSEA-4 and TRA-1–60 Labelled Undifferentiated Human Embryonic Stem Cells from A Heterogeneous Cell Population Using Magnetic-Activated Cell Sorting (MACS) and Fluorescence-Activated Cell Sorting (FACS) , 2009, Stem Cell Reviews and Reports.

[28]  Wenjun Guo,et al.  Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2 , 2008, Nature Biotechnology.

[29]  Eric D. Adler,et al.  Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population , 2008, Nature.

[30]  E. Kroon,et al.  Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo , 2008, Nature Biotechnology.

[31]  O. Isacson,et al.  Markers and Methods for Cell Sorting of Human Embryonic Stem Cell‐Derived Neural Cell Populations , 2007, Stem cells.

[32]  S. Nishikawa,et al.  A ROCK inhibitor permits survival of dissociated human embryonic stem cells , 2007, Nature Biotechnology.

[33]  A. Maitra,et al.  Characterization of a New NIH‐Registered Variant Human Embryonic Stem Cell Line, BG01V: A Tool for Human Embryonic Stem Cell Research , 2006, Stem cells.

[34]  J. Thomson,et al.  Derivation of human embryonic stem cells in defined conditions , 2006, Nature Biotechnology.

[35]  Chunhui Xu,et al.  Feeder-free growth of undifferentiated human embryonic stem cells , 2001, Nature Biotechnology.

[36]  P. Andrews,et al.  The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycan. , 1999, Cancer research.

[37]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[38]  Tiago G Fernandes,et al.  Stem cell bioprocessing for regenerative medicine , 2014 .

[39]  Jiho Jang,et al.  Selective Depletion of SSEA-3- and TRA-1-60-Positive Undifferentiated Human Embryonic Stem Cells by Magnetic Activated Cell Sorter (MACS) , 2011 .

[40]  Z. Karabekian,et al.  Stem Cell Rev and Rep , 2010 .